Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Feb 24;6(3):25.
doi: 10.3390/jcm6030025.

Mitochondrial Modification Techniques and Ethical Issues

Affiliations

Mitochondrial Modification Techniques and Ethical Issues

Lucía Gómez-Tatay et al. J Clin Med. .

Abstract

Current strategies for preventing the transmission of mitochondrial disease to offspring include techniques known as mitochondrial replacement and mitochondrial gene editing. This technology has already been applied in humans on several occasions, and the first baby with donor mitochondria has already been born. However, these techniques raise several ethical concerns, among which is the fact that they entail genetic modification of the germline, as well as presenting safety problems in relation to a possible mismatch between the nuclear and mitochondrial DNA, maternal mitochondrial DNA carryover, and the "reversion" phenomenon. In this essay, we discuss these questions, highlighting the advantages of some techniques over others from an ethical point of view, and we conclude that none of these are ready to be safely applied in humans.

Keywords: CRISPR; TALENs; ethics; gene editing; maternal spindle transfer; mitochondrial disease; mitochondrial replacement; polar body transfer; pronuclear transfer.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Pronuclear transfer.
Figure 2
Figure 2
Maternal spindle transfer.
Figure 3
Figure 3
(A) first polar body transfer; (B) second polar body transfer.

References

    1. Van der Giezen M., Tovar J. Degenerate mitochondria. EMBO Rep. 2005;6:525–530. doi: 10.1038/sj.embor.7400440. - DOI - PMC - PubMed
    1. Gorman G.S., Chinnery P.F., DiMauro S., Hirano M., Koga Y., McFarland R., Suomalainen A., Thorburn D.R., Zeviani M., Turnbull D.M. Mitochondrial diseases. Nat. Rev. Dis. Primers. 2016 doi: 10.1038/nrdp.2016.80. - DOI - PubMed
    1. Nass S., Nass M.M.K. Intramitochondrial fibers with DNA characteristics II. Enzymatic and Other Hydrolytic Treatments. J. Cell Biol. 1963;19:613–629. doi: 10.1083/jcb.19.3.613. - DOI - PMC - PubMed
    1. Andrews R.M., Kubacka I., Chinnery P.F., Lightowlers R.N., Turnbull D.M., Howell N. Reanalysis and revision of the Cambridge reference sequence for human mitochondrial DNA. Nat. Genet. 1999;23:147. - PubMed
    1. Lapuente-Brun E., Moreno-Loshuertos R., Acín-Pérez R., Latorre-Pellicer A., Colás C., Balsa E., Perales-Clemente E., Quirós P.M., Calvo E., Rodríguez-Hernández M.A., et al. Supercomplex assembly determines electron flux in the mitochondrial electron transport chain. Science. 2013;340:1567–1570. doi: 10.1126/science.1230381. - DOI - PubMed

LinkOut - more resources